Synovate acquires Russia's Comcon
This article was originally published in Scrip
Executive Summary
Synovate, an international market research company, part of the UK Aegis group, has acquired a majority stake in Russia's Comcon which has a healthcare division, Comcon Pharma. It plans to integrate Comcon into its existing local business within the next few months after which they will both operate under the Synovate brand.